- Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia2010 | Second Faculty of Medicine
- Ibrutinib plus RICE/RVICI for R/R mature B-NHL in children/young adults: SPARKLE trial2023 | Second Faculty of Medicine
- Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy2020 | Second Faculty of Medicine